Adjuvant therapeutic vaccination in patients with non-small cell lung cancer made lymphopenic and reconstituted with autologous PBMC: first clinical experience and evidence of an immune response

BACKGROUND: Given the considerable toxicity and modest benefit of adjuvant chemotherapy for non-small cell lung cancer (NSCLC), there is clearly a need for new treatment modalities in the adjuvant setting. Active specific immunotherapy may represent such an option. However, clinical responses have b...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Rüttinger, Dominik, van den Engel, Natasja K, Winter, Hauke, Schlemmer, Marcus, Pohla, Heike, Grützner, Stefanie, Wagner, Beate, Schendel, Dolores J, Fox, Bernard A, Jauch, K-W, Hatz, Rudolf A
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2007
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2020458/
https://ncbi.nlm.nih.gov/pubmed/17868452
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-5-43
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन